Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors
Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors
Recruiting · NCT06088004 · Registry updated 2026-09-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors | Solid Tumor, Adult | Recruiting | Phase 1 / Phase 2 | 2026-09-23 | NCT06088004 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Abogen Life Sciences (Shanghai) Co., Ltd. | 3 |
| Suzhou Abogen Biosciences Co., Ltd. | 11 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Hospital Chinese Academy of Medical Sciences | Beijing | China | 33 |
| Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center | Shenzhen | China | 6 |
| Guangxi Medical University Cancer Hospital | Nanning | China | 17 |
| Shanxi Cancer hospital | Shanxi | China | 2 |
| Sun Yat-Sen University Cancer Center | Guangzhou | China | 66 |